Female Cardiovascular Health
Cross-source consensus on Female Cardiovascular Health from 1 sources and 5 claims.
1 sources · 5 claims
Uses
How it works
Risks & contraindications
Highlighted claims
- Estrogen directly triggers nitric oxide production through the endothelial pathway. — Nitric Oxide: The Molecule of Flow
- Declining estrogen in perimenopause weakens endothelial nitric oxide signaling. — Nitric Oxide: The Molecule of Flow
- After menopause, women's cardiovascular disease risk rises to match men's. — Nitric Oxide: The Molecule of Flow
- Perimenopausal symptoms such as blood pressure elevations, palpitations, anxiety, sleep disruption, and circulatory changes are linked to reduced nitric oxide caused by falling estrogen. — Nitric Oxide: The Molecule of Flow
- Hormone replacement therapy and estrogen-supportive interventions can help preserve endothelial nitric oxide pathway function. — Nitric Oxide: The Molecule of Flow